首页 | 本学科首页   官方微博 | 高级检索  
检索        

晚期胰腺癌的持续腹腔动脉插管化疗
引用本文:熊小强,朱兆华.晚期胰腺癌的持续腹腔动脉插管化疗[J].实用癌症杂志,1999,14(3):208-210.
作者姓名:熊小强  朱兆华
作者单位:中山医科大学孙逸仙纪念医院消化内科
摘    要:为了观察和评价晚期胰腺癌持续腹腔动脉插管化疗效果,对7例晚期胰腺癌患者行腹腔动脉插管并留置,6例采用THPADM+HCPT+CF/5Fu方案,另1例采用Gemcitabine+CF/5Fu方案,持续滴注4d。结果完全缓解1例,部分缓解3例,无变化2例,进展1例,有效率为57.1%(4/7),临床受益疗效71.4%(5/7)。2例已死亡,5例生存,中位生存期5个月。结果表明持续腹腔动脉插管化疗对晚期胰腺癌有较好疗效,值得临床进一步观察研究。

关 键 词:胰腺癌  联合化疗  动脉插管

Continuous Coeliac Arterial Infusion Polychemotherapy for Advanced Pancreatic Cancer
Xiong Xiaoqiang,Zhu zhaohua,Wen Zhuofu,et al.Continuous Coeliac Arterial Infusion Polychemotherapy for Advanced Pancreatic Cancer[J].The Practical Journal of Cancer,1999,14(3):208-210.
Authors:Xiong Xiaoqiang  Zhu zhaohua  Wen Zhuofu  
Abstract:To observe and evaluate the efficiency of continuous coeliac arterial infusion polychemotherapy on advanced pancreatic cancer.4 day long continuous coeliac arterial infusion polychemotherapy was performed in 7 patients with advanced pancreatic cancer,the regimen of pirarubicin,hydroxycamptothecine,calcium folinate and fluorouracil was used in 6 cases and gemcitabine,calcium folinate and fluorouracil in 1.Short term efficiency:complete remission (CR) occured in 1 cases,partial remission(PR) in3,no change(NC) in 2 and progression disease(PD) in 1.The overall response rate (RR) was 57% (4/7).Clinical benefit response(CBR) was 71%(5/7).The median survival time was 5 months.5 patients survived and 2 patients died.Continuous coeliac arterial infusion polychemotherapy is more effective to advanced pancreatic cancer and worth further study.
Keywords:Pancreatic cancer  Polychemotherapy  Arterial infusion  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号